Year: 2018
Type: editorial
Abstract: Colorectal cancer (CRC) is one of the most common malignancies in the United States and Europe (1,2). Detection and removal of colon polyps or early cancer is associated with a reduction in mortality from CRC (3). The adenoma detection rate (ADR) during screening colonoscopy is recommended as a measure of the quality of colonoscopic examination. Corley et al. reveled that a 1% increase in the ADR was associated with a 3% decrease in interval CRC incidence (4). More recently, a prospective study from Poland et al . showed 1% increase in the ADR was associated with a 6% reduced risk of interval CRC (5). However, the ADR varies widely, largely depending on the ability of gastroenterologist, time spent, and preparation quality. Unfortunately, adenoma miss rate remains high (6–27%) (6), despite of novel technologies, devises, and interpretation. It is partly because of well recognized blind spots on colonoscopies.
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Awards: Clinical application of biomarker associated with resistance of molecular target therapy for GIST based on comprehensive molecular analysis in a large scale of clinical samples(Fostering Joint International Research), The identification of molecular markers associated with resistance for molecular targeted agents in GIST
OpenAlex ID: W2906036756